{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:37:47Z","timestamp":1794609467487,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23 AR081423"],"award-info":[{"award-number":["K23 AR081423"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To evaluate circulating levels of intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) in patients with dermatomyositis (DM) and DM associated interstitial lung disease (DM-ILD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a cross-sectional study in plasma samples from DM patients and matched healthy controls. Plasma ICAM-1 and VCAM-1 (CAM) levels were measured by ELISA. The activity of paraoxonase-1 (PON1), a high density lipoprotein (HDL) associated antioxidative enzyme was measured using paraoxonase, arylesterase and lactonase assays. Association analysis was performed between clinical predictors and CAM levels. We analyzed whether CAM levels have a mediating role in the association between PON1 activity and IIM outcomes using causal mediation analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Plasma samples from 83 DM patients with anti-Jo1 (<jats:italic>n<\/jats:italic>\u2009=\u200924), MDA5 (<jats:italic>n<\/jats:italic>\u2009=\u200929), and TIF1gamma (<jats:italic>n<\/jats:italic>\u2009=\u200930) and 28 age and sex matched healthy controls were analyzed. Plasma CAM levels were significantly higher in DM patients compared to controls. CAM levels were particularly higher in anti-MDA5\u2009+\u2009DM patients compared to other autoantibody groups and in DM-ILD compared to DM without ILD. Higher ICAM-1 levels correlated low PON1 lactonase activity as well as worse restrictive lung physiology in multivariate models. Mediation analysis showed that 54% of the effect of low lactonase on worse DLCO was mediated through ICAM-1.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Plasma CAM levels were higher in DM patients compared to healthy controls, particularly in DM patients with ILD. Our analyses support a pathway of low PON1 lactonase activity representing poor HDL function with low protective capacity of microvessels allowing increased endothelial activation leading to DM and DM-ILD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13075-025-03520-z","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T02:25:42Z","timestamp":1741400742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Plasma levels of adhesion molecules are elevated in dermatomyositis-interstitial lung disease and associated with low paraoxonase-1 activity"],"prefix":"10.1186","volume":"27","author":[{"given":"Sangmee Sharon","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ani","family":"Shahbazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa T.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Charles-Schoeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"issue":"1","key":"3520_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","volume":"77","author":"GC Dobloug","year":"2018","unstructured":"Dobloug GC, Svensson J, Lundberg IE, Holmqvist M. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis. 2018;77(1):40\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211402. Epub 2017\/08\/18.","journal-title":"Ann Rheum Dis"},{"key":"3520_CR2","doi-asserted-by":"publisher","unstructured":"Johnson C, Pinal-Fernandez I, Parikh R, Paik J, Albayda J, Mammen AL, Christopher-Stine L, Danoff S. Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung. 2016;194(5):733-7. Epub 2016\/05\/12. https:\/\/doi.org\/10.1007\/s00408-016-9896-x. PubMed PMID: 27166633.","DOI":"10.1007\/s00408-016-9896-x"},{"key":"3520_CR3","doi-asserted-by":"publisher","unstructured":"Grundtman C, Lundberg IE. Pathogenesis of idiopathic inflammatory myopathies. Curr Rheumatol Rep. 2006;8(3):188\u201395. Epub 2006\/08\/12. https:\/\/doi.org\/10.1007\/s11926-996-0024-4. PubMed PMID: 16901076.","DOI":"10.1007\/s11926-996-0024-4"},{"key":"3520_CR4","doi-asserted-by":"publisher","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374. Epub 2002\/12\/20. https:\/\/doi.org\/10.1038\/nature01323. PubMed PMID: 12490960.","DOI":"10.1038\/nature01323"},{"issue":"11","key":"3520_CR5","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","volume":"27","author":"E Galkina","year":"2007","unstructured":"Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(11):2292\u2013301. https:\/\/doi.org\/10.1161\/ATVBAHA.107.149179. Epub 2007\/08\/04. PubMed PMID: 17673705.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3520_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","volume":"54","author":"RR Packard","year":"2008","unstructured":"Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54(1):24\u201338. https:\/\/doi.org\/10.1373\/clinchem.2007.097360. Epub 2007\/12\/28.","journal-title":"Clin Chem"},{"issue":"3","key":"3520_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jjcc.2008.12.007","volume":"53","author":"E Zakynthinos","year":"2009","unstructured":"Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol. 2009;53(3):317\u201333. https:\/\/doi.org\/10.1016\/j.jjcc.2008.12.007. Epub 2009\/05\/30.","journal-title":"J Cardiol"},{"issue":"1\u20132","key":"3520_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-5728(95)00045-4","volume":"59","author":"DS Tews","year":"1995","unstructured":"Tews DS, Goebel HH. Expression of cell adhesion molecules in inflammatory myopathies. J Neuroimmunol. 1995;59(1\u20132):185\u201394. https:\/\/doi.org\/10.1016\/0165-5728(95)00045-4. Epub 1995\/06\/01.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"3520_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336","volume":"43","author":"I Lundberg","year":"2000","unstructured":"Lundberg I, Kratz AK, Alexanderson H, Patarroyo M. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 2000;43(2):336\u201348. https:\/\/doi.org\/10.1002\/1529-0131(200002)43:2%3C336. Epub 2000\/02\/29.","journal-title":"Arthritis Rheum"},{"key":"3520_CR10","doi-asserted-by":"publisher","unstructured":"Kumamoto T, Abe T, Ueyama H, Sugihara R, Shigenaga T, Tsuda T. Elevated soluble intercellular adhesion molecules-1 in inflammatory myopathy. Acta Neurol Scand. 1997;95(1):34\u20137. Epub 1997\/01\/01. https:\/\/doi.org\/10.1111\/j.1600-0404.1997.tb00065.x. PubMed PMID: 9048983.","DOI":"10.1111\/j.1600-0404.1997.tb00065.x"},{"issue":"8","key":"3520_CR11","first-page":"1623","volume":"33","author":"D Figarella-Branger","year":"2006","unstructured":"Figarella-Branger D, Schleinitz N, Boutiere-Albanese B, Camoin L, Bardin N, Guis S, Pouget J, Cognet C, Pellissier JF, Dignat-George F. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. J Rheumatol. 2006;33(8):1623\u201330. Epub 2006\/08\/02. PubMed PMID: 16881117.","journal-title":"J Rheumatol"},{"issue":"1","key":"3520_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/1756-185X.12039","volume":"16","author":"VS Limaye","year":"2013","unstructured":"Limaye VS, Bonder CS, Sun WY, Lester S, Roberts-Thomson PJ, Blumbergs P. Levels of soluble adhesion molecules and their associations in inflammatory myositis. Int J Rheum Dis. 2013;16(1):99\u2013101. https:\/\/doi.org\/10.1111\/1756-185X.12039. Epub 2013\/02\/28.","journal-title":"Int J Rheum Dis"},{"key":"3520_CR13","doi-asserted-by":"publisher","unstructured":"Kubo M, Ihn H, Yamane K, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis\/dermatomyositis. Br J Dermatol. 2000;143(2):392-8. Epub 2000\/08\/22. https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03668.x. PubMed PMID: 10951151.","DOI":"10.1046\/j.1365-2133.2000.03668.x"},{"issue":"9","key":"3520_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0022-2275(20)33462-3","volume":"41","author":"M Navab","year":"2000","unstructured":"Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res. 2000;41(9):1495\u2013508. Epub 2000\/09\/07. PubMed PMID: 10974057.","journal-title":"J Lipid Res"},{"issue":"9","key":"3520_CR15","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0022-2275(20)33461-1","volume":"41","author":"M Navab","year":"2000","unstructured":"Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res. 2000;41(9):1481\u201394. Epub 2000\/09\/07. PubMed PMID: 10974056.","journal-title":"J Lipid Res"},{"issue":"6","key":"3520_CR16","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1093\/rheumatology\/keab795","volume":"61","author":"SS Bae","year":"2022","unstructured":"Bae SS, Shahbazian A, Wang J, Golub I, Oganesian B, Dowd T, Vayngortin B, Wang R, Elashoff D, Reddy ST, Charles-Schoeman C. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2022;61(6):2512\u201323. https:\/\/doi.org\/10.1093\/rheumatology\/keab795. Epub 2021\/10\/27.","journal-title":"Rheumatology (Oxford)"},{"key":"3520_CR17","doi-asserted-by":"publisher","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, Garcia-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, International Myositis Classification Criteria Project Consortium tER, the Juvenile Dermatomyositis Cohort Biomarker S, Repository. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69(12):2271\u201382. https:\/\/doi.org\/10.1002\/art.40320. Epub 2017\/11\/07.","DOI":"10.1002\/art.40320"},{"issue":"Suppl 11","key":"3520_CR18","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient\/parent global activity, manual muscle testing (MMT), health assessment questionnaire (HAQ)\/Childhood health assessment questionnaire (C-HAQ), childhood myositis assessment scale (CMAS), myositis disease activity assessment tool (MDAAT), disease activity score (DAS), short form 36 (SF-36), child health questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitative muscle testing (QMT), myositis functional index-2 (FI-2), myositis activities profile (MAP), inclusion body myositis functional rating scale (IBMFRS), cutaneous dermatomyositis disease area and severity index (CDASI), cutaneous assessment tool (CAT), dermatomyositis skin severity index (DSSI), skindex, and dermatology life quality index (DLQI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S118\u201357. https:\/\/doi.org\/10.1002\/acr.20532. Epub 2012\/05\/25.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"3520_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, Pneumonias AECII. An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST. PubMed PMID: 24032382; PMCID: PMC5803655.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3520_CR20","doi-asserted-by":"publisher","first-page":"16848","DOI":"10.1038\/s41598-020-74016-w","volume":"10","author":"C Charles-Schoeman","year":"2020","unstructured":"Charles-Schoeman C, Wang J, Shahbazian A, Lee YY, Wang X, Grijalva V, Brahn E, Shih DM, Devarajan A, Montano C, Lusis AJ, Reddy ST. Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice. Sci Rep. 2020;10(1):16848. https:\/\/doi.org\/10.1038\/s41598-020-74016-w. PubMed PMID: 33033318; PMCID: PMC7546628. Epub 2020\/10\/10.","journal-title":"Sci Rep"},{"key":"3520_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research \u2013 conceptual, strategic, and statistical considerations. J Personal Soc Psychol. 1986;51:1173\u201382.","journal-title":"J Personal Soc Psychol"},{"issue":"4","key":"3520_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199407000-00008","volume":"53","author":"JL De Bleecker","year":"1994","unstructured":"De Bleecker JL, Engel AG. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol. 1994;53(4):369\u201376. https:\/\/doi.org\/10.1097\/00005072-199407000-00008. Epub 1994\/07\/01.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"3520_CR23","first-page":"33","volume":"47","author":"A Jain","year":"2009","unstructured":"Jain A, Sharma MC, Sarkar C, Bhatia R, Singh S, Handa R. Increased expression of cell adhesion molecules in inflammatory myopathies: diagnostic utility and pathogenetic insights. Folia Neuropathol. 2009;47(1):33\u201342. Epub 2009\/04\/09. PubMed PMID: 19353432.","journal-title":"Folia Neuropathol"},{"key":"3520_CR24","doi-asserted-by":"publisher","unstructured":"Pulito-Cueto V, Remuzgo-Martinez S, Genre F, Atienza-Mateo B, Mora-Cuesta VM, Iturbe-Fernandez D, Lera-Gomez L, Mora-Gil MS, Portilla V, Corrales A, Blanco R, Cifrian JM, Gonzalez-Gay MA, Lopez-Mejias R, E-Selectin. ICAM-1, and ET-1 biomarkers address the concern of the challenging diagnosis of interstitial lung disease in patients with autoimmune diseases. Int J Mol Sci. 2023;24(15). https:\/\/doi.org\/10.3390\/ijms241512518. Epub 2023\/08\/12.","DOI":"10.3390\/ijms241512518"},{"key":"3520_CR25","doi-asserted-by":"crossref","unstructured":"McGroder CF, Aaron CP, Bielinski SJ, Kawut SM, Tracy RP, Raghu G, Barr RG, Lederer DJ, Podolanczuk AJ. Circulating adhesion molecules and subclinical interstitial lung disease: the multi-ethnic study of atherosclerosis. Eur Respir J. 2019;54(3). Epub 2019\/08\/03. doi: 10.1183\/13993003.00295-2019. PubMed PMID: 31371443; PMCID: PMC7003619.","DOI":"10.1183\/13993003.00295-2019"},{"issue":"4","key":"3520_CR26","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1080\/08820139.2021.1897611","volume":"51","author":"M Lin","year":"2022","unstructured":"Lin M, Yang C, Liu X, Zhao S, Tian B, Hou X, Xu J, Yang P. Increased levels of VCAM-1 in Sera and VLA-4 expression on neutrophils in dermatomyositis with interstitial lung disease. Immunol Invest. 2022;51(4):980\u201392. PubMed PMID: 33724131.","journal-title":"Immunol Invest"},{"issue":"5","key":"3520_CR27","first-page":"903","volume":"33","author":"M Funauchi","year":"2006","unstructured":"Funauchi M, Shimadsu H, Tamaki C, Yamagata T, Nozaki Y, Sugiyama M, Ikoma S, Kinoshita K. Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis. J Rheumatol. 2006;33(5):903\u20136. Epub 2006\/05\/03. PubMed PMID: 16652421.","journal-title":"J Rheumatol"},{"issue":"9","key":"3520_CR28","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/jcmm.12864","volume":"20","author":"T Asdonk","year":"2016","unstructured":"Asdonk T, Steinmetz M, Krogmann A, Strocker C, Lahrmann C, Motz I, Paul-Krahe K, Flender A, Schmitz T, Barchet W, Hartmann G, Nickenig G, Zimmer S. MDA-5 activation by cytoplasmic double-stranded RNA impairs endothelial function and aggravates atherosclerosis. J Cell Mol Med. 2016;20(9):1696\u2013705. https:\/\/doi.org\/10.1111\/jcmm.12864. Epub 2016\/05\/01.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"3520_CR29","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1002\/art.24683","volume":"60","author":"S Barbasso Helmers","year":"2009","unstructured":"Barbasso Helmers S, Englund P, Engstrom M, Ahlin E, Fathi M, Janciauskiene S, Heimburger M, Ronnelid J, Lundberg IE. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells. Arthritis Rheum. 2009;60(8):2524\u201330. https:\/\/doi.org\/10.1002\/art.24683. Epub 2009\/08\/01.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3520_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/thoraxjnl-2016-209568","volume":"72","author":"AJ Podolanczuk","year":"2017","unstructured":"Podolanczuk AJ, Raghu G, Tsai MY, Kawut SM, Peterson E, Sonti R, Rabinowitz D, Johnson C, Barr RG, Hinckley Stukovsky K, Hoffman EA, Carr JJ, Ahmed FS, Jacobs DR, Watson K, Shea SJ, Lederer DJ. Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study. Thorax. 2017;72(5):472\u20134. https:\/\/doi.org\/10.1136\/thoraxjnl-2016-209568. Epub 2017\/01\/29.","journal-title":"Thorax"},{"key":"3520_CR31","doi-asserted-by":"crossref","unstructured":"Bae SS, Chang LC, Merkin SS, Elashoff D, Ishigami J, Matsushita K, Charles-Schoeman C. Major lipids and future risk of pneumonia: 20-year observation of the atherosclerosis risk in communities (ARIC) study cohort. Am J Med. 2021;134(2):243\u201351 e2. Epub 2020\/08\/20. doi: 10.1016\/j.amjmed.2020.07.022. PubMed PMID: 32814017; PMCID: PMC7870521.","DOI":"10.1016\/j.amjmed.2020.07.022"},{"issue":"1","key":"3520_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12016-020-08814-5","volume":"60","author":"T Vojinovic","year":"2021","unstructured":"Vojinovic T, Cavazzana I, Ceruti P, Fredi M, Modina D, Berlendis M, Franceschini F. Predictive features and clinical presentation of interstitial lung disease in inflammatory myositis. Clin Rev Allergy Immunol. 2021;60(1):87\u201394. PubMed PMID: 33141387; PMCID: PMC7819919.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9943","key":"3520_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626\u201335. Epub 2014\/08\/19. doi: 10.1016\/S0140-6736(14)61177-6. PubMed PMID: 25131982.","journal-title":"Lancet"},{"issue":"10","key":"3520_CR34","doi-asserted-by":"publisher","first-page":"e78322","DOI":"10.1371\/journal.pone.0078322","volume":"8","author":"YI Wang","year":"2013","unstructured":"Wang YI, Bettaieb A, Sun C, DeVerse JS, Radecke CE, Mathew S, Edwards CM, Haj FG, Passerini AG, Simon SI. Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress. PLoS ONE. 2013;8(10):e78322. https:\/\/doi.org\/10.1371\/journal.pone.0078322. Epub 2013\/11\/10.","journal-title":"PLoS ONE"},{"key":"3520_CR35","doi-asserted-by":"crossref","unstructured":"Toth PP. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vasc Health Risk Manag. 2016;12:171\u201383. Epub 2016\/05\/27. doi: 10.2147\/VHRM.S104369. PubMed PMID: 27226718; PMCID: PMC4866746.","DOI":"10.2147\/VHRM.S104369"},{"issue":"7","key":"3520_CR36","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1253\/circj.CJ-11-0460","volume":"75","author":"S Imaizumi","year":"2011","unstructured":"Imaizumi S, Navab M, Morgantini C, Charles-Schoeman C, Su F, Gao F, Kwon M, Ganapathy E, Meriwether D, Farias-Eisner R, Fogelman AM, Reddy ST. Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. Circ J. 2011;75(7):1533\u20138. PubMed PMID: 21628835; PMCID: PMC3625624.","journal-title":"Circ J"},{"issue":"7","key":"3520_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11926-022-01076-4","volume":"24","author":"K McLellan","year":"2022","unstructured":"McLellan K, Papadopoulou C. Update on biomarkers of vasculopathy in juvenile and adult myositis. Curr Rheumatol Rep. 2022;24(7):227\u201337. https:\/\/doi.org\/10.1007\/s11926-022-01076-4. Epub 2022\/06\/11.","journal-title":"Curr Rheumatol Rep"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03520-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03520-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03520-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T14:19:15Z","timestamp":1741443555000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03520-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3520"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03520-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects gave written informed consent for the study approved by the Human Research Subject Protection Committee at UCLA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Charles-Schoeman has grant support from Alexion, Priovant, CSL Behring, and Janssen, is a consultant for Boehringer Ingelheim, Recludix, and Galapagos and has grant support and is a consultant for Octapharma, Pfizer, Abbvie, and Bristol Myers Squibb. All other authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}